BioELife Corp. (LITH)
OTCMKTS · Delayed Price · Currency is USD
0.0000
+0.0000 (0.00%)
At close: Oct 24, 2024

BioELife Income Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTM FY 2018 FY 2017 FY 2016 FY 2015 FY 2014 2013 - 2009
Period Ending
Sep '19 Dec '18 Dec '17 Dec '16 Dec '15 Dec '14 2013 - 2009
Cost of Revenue
0000-0.4
Upgrade
Gross Profit
-0-0-0-0--0.4
Upgrade
Selling, General & Admin
0.090.070.080.10.060.07
Upgrade
Operating Expenses
0.090.070.120.10.060.07
Upgrade
Operating Income
-0.09-0.07-0.13-0.1-0.06-0.46
Upgrade
Interest Expense
-0.02-0.08-0.12-0.11-0.04-0.03
Upgrade
Currency Exchange Gain (Loss)
-0-0.04----
Upgrade
EBT Excluding Unusual Items
-0.11-0.2-0.25-0.21-0.1-0.5
Upgrade
Gain (Loss) on Sale of Investments
-0.48-0.82----
Upgrade
Other Unusual Items
0.680.68--0.02-
Upgrade
Pretax Income
-0.59-0.34-0.25-0.21-0.08-0.5
Upgrade
Net Income
-0.59-0.34-0.25-0.21-0.08-0.5
Upgrade
Net Income to Common
-0.59-0.34-0.25-0.21-0.08-0.5
Upgrade
Shares Outstanding (Basic)
332221
Upgrade
Shares Outstanding (Diluted)
332221
Upgrade
Shares Change (YoY)
33.70%6.32%8.14%19.67%67.85%8.97%
Upgrade
EPS (Basic)
-0.17-0.13-0.10-0.09-0.04-0.44
Upgrade
EPS (Diluted)
-0.17-0.13-0.10-0.09-0.04-0.44
Upgrade
Free Cash Flow
-0.13-0.08-0.12-0.13-0.03-0.04
Upgrade
Free Cash Flow Per Share
-0.04-0.03-0.05-0.06-0.02-0.03
Upgrade
EBIT
-0.09-0.07-0.13-0.1-0.06-0.46
Upgrade
Source: S&P Capital IQ. Standard template. Financial Sources.